184 related articles for article (PubMed ID: 10077475)
1. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
Karra SR; Schibli R; Gali H; Katti KV; Hoffman TJ; Higginbotham C; Sieckman GL; Volkert WA
Bioconjug Chem; 1999; 10(2):254-60. PubMed ID: 10077475
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
[TBL] [Abstract][Full Text] [Related]
3. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
[TBL] [Abstract][Full Text] [Related]
4. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.
Smith CJ; Gali H; Sieckman GL; Higginbotham C; Volkert WA; Hoffman TJ
Bioconjug Chem; 2003; 14(1):93-102. PubMed ID: 12526698
[TBL] [Abstract][Full Text] [Related]
5. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
6. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
Ma L; Yu P; Veerendra B; Rold TL; Retzloff L; Prasanphanich A; Sieckman G; Hoffman TJ; Volkert WA; Smith CJ
Mol Imaging; 2007; 6(3):171-80. PubMed ID: 17532883
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.
Höhne A; Mu L; Honer M; Schubiger PA; Ametamey SM; Graham K; Stellfeld T; Borkowski S; Berndorff D; Klar U; Voigtmann U; Cyr JE; Friebe M; Dinkelborg L; Srinivasan A
Bioconjug Chem; 2008 Sep; 19(9):1871-9. PubMed ID: 18754574
[TBL] [Abstract][Full Text] [Related]
9. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ
Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues.
Baidoo KE; Lin KS; Zhan Y; Finley P; Scheffel U; Wagner HN
Bioconjug Chem; 1998; 9(2):218-25. PubMed ID: 9548537
[TBL] [Abstract][Full Text] [Related]
11. A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier.
Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Pili R; Pomper M; Carducci M; Wagner HN
Bioconjug Chem; 2004; 15(6):1416-23. PubMed ID: 15546210
[TBL] [Abstract][Full Text] [Related]
12. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
Maina T; Nock BA; Zhang H; Nikolopoulou A; Waser B; Reubi JC; Maecke HR
J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
[TBL] [Abstract][Full Text] [Related]
13. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor.
Lane SR; Veerendra B; Rold TL; Sieckman GL; Hoffman TJ; Jurisson SS; Smith CJ
Nucl Med Biol; 2008 Apr; 35(3):263-72. PubMed ID: 18355681
[TBL] [Abstract][Full Text] [Related]
14. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA
J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
[TBL] [Abstract][Full Text] [Related]
15. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.
La Bella R; Garcia-Garayoa E; Bahler M; Bläuenstein P; Schibli R; Conrath P; Tourwé D; Schubiger PA
Bioconjug Chem; 2002; 13(3):599-604. PubMed ID: 12009951
[TBL] [Abstract][Full Text] [Related]
16. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of C-terminal hydroxamide analogues of bombesin.
Devin C; Bernad N; Cristau M; Artis-Noel AM; Heitz A; Fehrentz JA; Martinez J
J Pept Sci; 1999 Apr; 5(4):176-84. PubMed ID: 10323197
[TBL] [Abstract][Full Text] [Related]
18. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
Smith CJ; Gali H; Sieckman GL; Hayes DL; Owen NK; Mazuru DG; Volkert WA; Hoffman TJ
Nucl Med Biol; 2003 Feb; 30(2):101-9. PubMed ID: 12623108
[TBL] [Abstract][Full Text] [Related]
19. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ
J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438
[TBL] [Abstract][Full Text] [Related]
20. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
